• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

Exploring Sodium Bicyclo[2.2.1]heptane-2-carboxylate (CAS No. 1262435-15-3): Properties, Applications, and Innovations

Sodium bicyclo[2.2.1]heptane-2-carboxylate (CAS No. 1262435-15-3) is a specialized organic compound gaining attention in pharmaceutical and chemical research due to its unique bicyclic structure. The bicyclo[2.2.1]heptane (norbornane) framework, combined with a carboxylate group, offers exceptional steric and electronic properties, making it valuable for drug design, catalysis, and material science. Researchers are increasingly exploring its potential as a chiral building block or ligand precursor in asymmetric synthesis, aligning with the growing demand for enantioselective methodologies.

In recent years, the compound’s water-soluble sodium salt form has become a focal point for applications requiring improved bioavailability or environmental compatibility. Its stability under physiological conditions makes it a candidate for prodrug development, a hot topic in biopharmaceutical innovation. Notably, the rise of green chemistry has spurred interest in derivatives like sodium bicyclo[2.2.1]heptane-2-carboxylate as eco-friendly alternatives in industrial processes, addressing concerns about solvent waste and toxicity.

The compound’s CAS No. 1262435-15-3 is frequently searched in academic and patent databases, reflecting its relevance in intellectual property (IP) landscapes. Startups and R&D teams are investigating its role in high-value fine chemicals, particularly for neuroactive drug intermediates, where rigid bicyclic structures enhance target selectivity. This aligns with trends in central nervous system (CNS) drug discovery, a sector experiencing rapid growth due to unmet medical needs.

From a synthetic perspective, the bicyclo[2.2.1]heptane core provides a platform for structural diversification. Chemists leverage its strain energy to facilitate ring-opening reactions or cascade cyclizations, topics trending in methodology papers and AI-assisted retrosynthesis tools. Computational studies on this compound often appear in discussions about molecular docking and 3D pharmacophore modeling, highlighting its interdisciplinary appeal.

In material science, the sodium salt’s anionic surfactant-like behavior is under scrutiny for nanoparticle stabilization or polymeric matrix modification. Such applications resonate with the booming nanotechnology sector, where search queries for “functionalized bicyclic additives” have surged. Additionally, its potential in biodegradable chelators taps into the global push for sustainable alternatives to EDTA derivatives.

Quality control of CAS 1262435-15-3 remains critical, with analytical techniques like HPLC-MS and NMR purity profiling being common search terms among purchasers. Suppliers emphasizing GMP-grade synthesis or low heavy-metal specifications cater to the stringent requirements of clinical-stage developers, a niche with expanding market demand.

Looking ahead, the intersection of sodium bicyclo[2.2.1]heptane-2-carboxylate with machine learning in chemistry presents untapped opportunities. Predictive algorithms could optimize its use in combinatorial libraries or catalytic systems, addressing frequent queries about “next-gen bicyclic platforms.” As regulatory landscapes evolve, this compound’s REACH compliance and toxicological profiles will likely dominate industry discussions, ensuring its place in future innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)